CONMED Corp — Director's Dealing 2017

Jun 5, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CONMED CORP (CNMD)
CIK: 0000816956
Period of Report: 2017-06-02

Reporting Person: JONAS DANIEL (EVP Legal Affairs,Gen. Counsel)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-06-02	Common Stock	M	2000	$26.09	Acquired	17372	Direct
2017-06-02	Common Stock	F	1369	$52.26	Disposed	16003	Direct
2017-06-02	Common Stock	M	4000	$32.93	Acquired	20003	Direct
2017-06-02	Common Stock	F	3068	$52.26	Disposed	16935	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-06-02	Sars (Stock Appreciation Rights)	$26.09	M	2000	Disposed	2022-06-01	Common Stock (2000)	Direct
2017-06-02	Sars (Stock Appreciation Rights)	$32.93	M	4000	Disposed	2023-06-01	Common Stock (4000)	Direct

Footnotes

F1: The stock appreciation rights ("SARs") were granted under the Company's 1999 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period.